_中国心血管病报告2018_概要_胡盛寿.pdfVIP

中国循环杂志 2019 年 3 月 第 34 卷 第 3 期（总第 249 期）Chinese Circulation Journal，March，2019，Vol. 34 No.3（Serial No.249） 209 特别报告 《中国心血管病报告 2018》 概要 胡盛寿，高润霖，刘力生，朱曼璐，王文，王拥军，吴兆苏，李惠君，顾东风，杨跃进， 郑哲，陈伟伟，代表中国心血管病报告编写组 摘要 中国心血管病防治工作在取得初步成效的同时，又面临新的严峻挑战。总体上看，中国心血管病患病率及死亡 率仍处于上升阶段。推算心血管病现患人数 2.9 亿，其中脑卒中 1 300 万，冠心病 1 100 万，肺原性心脏病 500 万， 心力衰竭 450 万，风湿性心脏病 250 万，先天性心脏病 200 万，高血压 2.45 亿；心血管病死亡率居首位，高于肿瘤 及其他疾病，占居民疾病死亡构成的 40% 以上，特别是农村近几年来心血管病死亡率持续高于城市。心脑血管病住 院总费用也在快速增加，2004 年至今，年均增速远高于国民生产总值增速。中国心血管病负担日渐加重，已成为重 大的公共卫生问题，防治心血管病刻不容缓。 关键词 心血管病；危险因素；患病率；死亡率 Summary of the 2018 Report on Cardiovascular Diseases in China HU Shengshou, GAO Runlin, LIU Lisheng, ZHU Manlu, WANG Wen, WANG Yongjun, WU Zhaosu, LI Huijun, GU Dongfeng, YANG Yuejin, ZHENG Zhe, CHEN Weiwei, on behalf of the Writing Committee of the Report on Cardiovascular Diseases in China. National Center for Cardiovascular Diseases and Fuwai Hospital, CAMS and PUMC , Beijing (100037), China Corresponding Author: HU Shengshou, Email: shengshouhu@ Abstract Even though the prevention and control of cardiovascular diseases (CVD) has made preliminary achievements, it is confronted with several new severe challenges. The prevalence and mortality of CVD in China is continuously rising. It is estimated that about 290 million patients suffer from CVD. The number of patients suffering from stroke, coronary heart disease, pulmonary heart disease, heart failure, rheumatic heart disease, congenital heart disease and hypertension are 13 million, 11 million, 5 million, 4.5 million, 2.5 million, 2 million and 245 million, respectively. CVD was still the leading cause of death in 2016, more than tumors or any other diseases. CVD-related deaths accounting for all deaths were more than 40%. The CVD mortality rate in rural areas has exceeded and co